Yubo Chai
- Pharmacology top 10%
- Infectious Diseases top 10%
-
- Cancer-related molecular mechanisms research 2
-
- Heart Failure Treatment and Management 3
- Viral Infections and Immunology Research 2
-
- RNA Research and Splicing 3
- Epigenetics and DNA Methylation 2
- Ubiquitin and proteasome pathways 2
-
- Immune Response and Inflammation 2
-
- Cancer-related Molecular Pathways 2
- Co-authors
- Jian‐Dong HuangLeo L. M. PoonJulian A. TannerRory M. WattHsiang‐Fu KungMarie C.M. LinMalik PeirisRichard M. Weinshilboum
- Journals
- Journal of Biological Chemistry (1 paper)SHILAP Revista de lepidopterología (3 papers)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Yubo Chai
23 papers receiving 599 citations
Peers
Comparison fields: 5 of 95
- Pharmacology 67
- Biological Psychiatry 19
- Infectious Diseases 133
- Cancer Research 102
- Applied Microbiology and Biotechnology 11
Countries citing papers authored by Yubo Chai
This map shows the geographic impact of Yubo Chai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yubo Chai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yubo Chai more than expected).
Fields of papers citing papers by Yubo Chai
This network shows the impact of papers produced by Yubo Chai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yubo Chai. The network helps show where Yubo Chai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yubo Chai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | Exosomal lncRNA ROR1-AS1 Derived from Tumor Cells Promotes Glioma Progression via Regulating miR-4686 | 2020 | 0 |
| 3 | Genetic and Clinical Characterization of HOXB2 in Glioma | 2020 | 2 |
| 4 | 2016 | 52 | |
| 5 | 2016 | 14 | |
| 6 | 2014 | 19 | |
| 7 | 2012 | 52 | |
| 8 | 2012 | 15 | |
| 9 | 2012 | 36 | |
| 10 | 2011 | 16 | |
| 11 | [Application of NIR spectroscopy to estimate of MFA and fiber length of Neosinocalamus a f finis]. | 2011 | 5 |
| 12 | 2010 | 61 | |
| 13 | 2010 | 45 | |
| 14 | 2010 | 17 | |
| 15 | 2009 | 1 | |
| 16 | 2009 | 3 | |
| 17 | 2007 | 2 | |
| 18 | 2003 | 168 | |
| 19 | Microsatellite DNA analysis of somatic cloned goats | 2002 | 0 |
| 20 | 2000 | 30 |
About Yubo Chai
Yubo Chai is a scholar working on Biological Psychiatry, Cancer Research and Molecular Biology, having authored 25 papers that have together received 606 indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (3 papers), RNA Research and Splicing (3 papers), Epigenetics and DNA Methylation (2 papers), Viral Infections and Immunology Research (2 papers), Immune Response and Inflammation (2 papers), Ubiquitin and proteasome pathways (2 papers), Cancer-related molecular mechanisms research (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Pharmacology (67 citations), Biological Psychiatry (19 citations) and Infectious Diseases (133 citations). Yubo Chai has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Jian‐Dong Huang, Leo L. M. Poon, Julian A. Tanner, Rory M. Watt, Hsiang‐Fu Kung, Marie C.M. Lin, Malik Peiris, Richard M. Weinshilboum, Junxuan Lü and Yuan Ji. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.